Historical overview of immunological tolerance

Cold Spring Harbor Perspectives in Biology

Volumn 4, Issue 4, 2012, Pages

  Schwartz, Ronald H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; IMMUNOLOGICAL TOLERANCE; REVIEW;

HUMANS; IMMUNE TOLERANCE;

EID: 84863888275     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a006908     Document Type: Article

References (178)

1. Abramson J, Giraud M, Benoist C, Mathis D. 2010. Aire's partners in the molecular control of immunological tolerance. Cell 140: 123-135.
2. Alegre ML, Frauwirth KA, Thompson CB. 2001. T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 1: 220-228.
3. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, et al. 2002. Projection of an immunological self shadow within the thymus by the Aire protein. Science 298: 1395-1401.
4. Apostolou I, von Boehmer H. 2004. In vivo instruction of suppressor commitment in nai{dotless}̈ve T cells. J Exp Med 199: 1401-1408.
5. Asherson GL, Stone SH. 1965. Selective and specific inhibition of 24 hour skin reactions in the guinea-pig. I. Immune deviation: Description of the phenomenon and the effect of splenectomy. Immunology 9: 205-217.
6. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190: 995-1004.
7. Atabani SF, Thio CL, Divanovic S, Trompette A, Belkaid Y, Thomas DL, Karp CL. 2005. Association of CTLA4 polymorphism with regulatory T cell frequency. Eur J Immunol 35: 2157-2162.
8. Avalos AM, Uccellini MB, Lenert P, Viglianti GA, Marshak-Rothstein A. 2010. FcgRIIB regulation of BCR/TLR-dependent autoreactive B-cell responses. Eur J Immunol 40: 2692-2698.
9. Azzam HS, Grinberg A, Lui K, Shen H, Shores EW, Love PE. 1998. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J Exp Med 188: 2301-2311.
10. Bacchetta R, Bigler M, Touraine JL, Parkman R, Tovo PA, Abrams J, de Waal Malefyt R, de Vries JE, Roncarolo MG. 1994. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 179: 493-502.
11. Bach JF. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347: 911-920.
12. + T regulatory cells and T regulatory type 1 cells. Diabetes 55: 1571-1580.
13. Bautista JL, Lio CW, Lathrop SK, Forbush K, Liang Y, Luo J, Rudensky AY, Hsieh CS. 2009. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat Immunol 10: 610-617.
14. Båve U, Magnusson M, Eloranta ML, Perers A, Alm GV, Rönnblom L. 2003. Fc g RIIa is expressed on natural IFN-a-producing cells (plasmacytoid dendritic cells) and is required for the IFN-a production induced by apoptotic cells combined with lupus IgG. J Immunol 171: 3296-3302.
15. + regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
16. Billingham RE, Brent L, Medawar PB. 1953. "Actively acquired tolerance" of foreign cells. Nature 172: 603-607.
17. Billingham RE, Brent L, Medawar PB. 1954. Quantitative studies on tissue transplantation immunity. II. The origin, strength and duration of actively and adoptively acquired immunity. Proc R Soc Lond B Biol Sci 143: 58-80.
18. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. 2001. Induction of dendritic cell differentiation by IFN-a in systemic lupus erythematosus. Science 294: 1540-1543.
19. Bluestone JA, Tang Q, Sedwick CE. 2008. T regulatory cells in autoimmune diabetes: Past challenges, future prospects. J Clin Immunol 28: 677-684.
20. Boackle SA, Holers VM, Chen X, Szakonyi G, Karp DR, Wakeland EK, Morel L. 2001. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 15: 775-785.
21. Bonasio R, Scimone ML, Schaerli P, Grabie N, Lichtman AH, von Andrian UH. 2006. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol 7: 1092-1100.
22. Bouaziz JD, Yanaba K, Tedder TF. 2008. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 224: 201-214.
23. Bour-Jordan H, Thompson HL, Bluestone JA. 2005. Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice. J Immunol 175: 5649-5655.
24. Bretscher P, Cohn M. 1970. A theory of self-nonself discrimination. Science 169: 1042-1049.
25. Burnet FM. 1957. A modification of Jerne's theory of antibody production using the concept of clonal selection. Aust J Sci 20: 67-69.
26. + regulatory T cells by TGF-b induction of transcription factor Foxp3. J Exp Med 198: 1875-1886.
27. + suppressor T cells. Nat Immunol 5: 469-471.
28. Chiodetti L, Choi S, Barber DL, Schwartz RH. 2006. Adaptive tolerance and clonal anergy are distinct biochemical states. J Immunol 176: 2279-2291.
29. Cohen-Solal JF, Jeganathan V, Grimaldi CM, Peeva E, Diamond B. 2006. Sex hormones and SLE: Influencing the fate of autoreactive B cells. Curr Top Microbiol Immunol 305: 67-88.
30. Croft M. 2003. Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev 14: 265-273.
31. Cyster JG, Hartley SB, Goodnow CC. 1994. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 371: 389-395.
32. Dale JB, Beachey EH. 1986. Sequence of myosin-cross-reactive epitopes of streptococcalMproteins. J Exp Med 164: 1785-1790.
33. Daniels MA, Teixeiro E, Gill J, Hausmann B, Roubaty D, Holmberg K, Werlen G, Hollander GA, Gascoigne NR, Palmer E. 2006. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature 444: 724-729.
34. Deane JA, Bolland S. 2006. Nucleic acid-sensing TLRs as modifiers of autoimmunity. J Immunol 177: 6573-6578.
35. Deane JA, Pisitkun P, Barrett RS, Feigenbaum L, Town T, Ward JM, Flavell RA, Bolland S. 2007. Control of Toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27: 801-810.
36. Dendrou CA, Plagnol V, Fung E, Yang JH, Downes K, Cooper JD, Nutland S, Coleman G, Himsworth M, Hardy M, et al. 2009. Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat Genet 41: 1011-1015.
37. Deng L, Mariuzza RA. 2007. Recognition of self-peptide-MHCcomplexes by autoimmune T-cell receptors. Trends Biochem Sci 32: 500-508.
38. Derbinski J, Kyewski B. 2010. How thymic antigen presenting cells sample the body's self-antigens. Curr Opin Immunol 22: 592-600.
39. Derbinski J, Schulte A, Kyewski B, Klein L. 2001. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2: 1032-1039.
40. Diamond B. 2008. Systemic autoimmunity. In Fundamental immunology, 6th ed. (ed. Paul WE), pp. 1291-1330. Lippincott Williams & Wilkins, Philadelphia.
41. Diana J, Brezar V, Beaudoin L, Dalod M, Mellor A, Tafuri A, von Herrath M, Boitard C, Mallone R, Lehuen A. 2011. Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay. J Exp Med 208: 729-745.
42. Dresser DW. 1962. Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen. Immunology 5: 378-388.
43. Durinovic-Belló I, Wu RP, Gersuk VH, Sanda S, Shilling HG, Nepom GT. 2010. Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin. Genes Immun11: 188-193.
44. Fairhurst AM, Wandstrat AE, Wakeland EK. 2006. Systemic lupus erythematosus: Multiple immunological phenotypes in a complex genetic disease. Adv Immunol 92: 1-69.
45. Fallarino F, Volpi C, Zelante T, Vacca C, Calvitti M, Fioretti MC, Puccetti P, Romani L, Grohmann U. 2009. IDO mediates TLR9-driven protection from experimental autoimmune diabetes. J Immunol 183: 6303-6312.
46. + regulatory T cells. Nat Immunol 4: 330-336.
47. Francisco LM, Sage PT, Sharpe AH. 2010. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 236: 219-242.
48. + regulatory T cell function. J Exp Med 196: 851-857.
49. Gajewski TF, Fitch FW. 1988. Anti-proliferative effect of IFN-g in immune regulation. I. IFN-g inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 140: 4245-4252.
50. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, et al. 2011. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3: 73ra20.
51. Gianani R. 2011. Beta cell regeneration in human pancreas. Semin Immunopath 33: 23-27.
52. Goodnow CC. 1992. Transgenic mice and analysis of B-cell tolerance. Annu Rev Immunol 10: 489-518.
53. Goodnow CC, Brink R, Adams E. 1991. Breakdown of selftolerance in anergic B lymphocytes. Nature 352: 532-536.
54. Green NM, Marshak-Rothstein A. 2011. Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin Immunol 23: 106-112.
55. Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu W, Parrish-Novak J, Foster D, Lofton-Day C, et al. 2000. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404: 995-999.
56. Grossman Z, Singer A. 1996. Tuning of activation thresholds explains flexibility in the selection and development of T cells in the thymus. Proc Natl Acad Sci 93: 14747-14752.
57. Gureau-de-Arellano M, Martinic M, Benoist C, Mathis D. 2009. Neonatal tolerance revisited: A perinatal window for Aire control of autoimmunity. J Exp Med 206: 1245-1252.
58. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132.
59. Hartley SB, Cooke MP, Fulcher DA, Harris AW, Cory S, Basten A, Goodnow CC. 1993. Elimination of self-reactive B lymphocytes proceeds in two stages: Arrested development and cell death. Cell 72: 325-335.
60. Hâsek M. 1953. Parabiosis of birds during embryonic development. Nature 2: 265-270.
61. Healy JI, Dolmetsch RE, Timmerman LA, Cyster JG, Thomas ML, Crabtree GR, Lewis RS, Goodnow CC. 1997. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 6: 419-428.
62. Hedrick SM. 2004. The acquired immune system: Avantage from beneath. Immunity 21: 607-615.
63. Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, Lee AT, Chung SA, Ferreira RC, Pant PV, et al. 2008. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358: 900-909.
64. Hori S, Nomura T, Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
65. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162: 5317-5326.
66. Janeway C Jr. 1992. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 13: 11-16.
67. Janeway CA Jr, Medzhitov R. 2002. Innate immune recognition. Annu Rev Immunol 20: 197-216.
68. + effector T cells: A mechanism for self-regulation. Mucosal Immunol 3: 239-246.
69. Jenkins MK, Schwartz RH. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 165: 302-319.
70. Jeon MS, Atfield A, Venuprasad K, Krawczyk C, Sarao R, Elly C, Yang C, Arya S, Bachmaier K, Su L, et al. 2004. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21: 167-177.
71. + T cells in murine experimental allergic encephalomyelitis. Science 256: 1213-1215.
72. Johnson BA III, Kahler DJ, Baban B, Chandler PR, Kang B, Shimoda M, Koni PA, Pihkala J, Vilagos B, Busslinger M, et al. 2010. B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase. Proc Natl Acad Sci 107: 10644-10648.
73. + regulatory T cells induced by an agonist self-peptide. Nat Immunol 2: 301-306.
74. Kabat EA, Wolf A, Bezer AE. 1946. Rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of brain tissue with adjuvants. Science 104: 362-363.
75. Kappler JW, Roehm N, Marrack P. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49: 273-280.
76. Karassa FB, Trikalinos TA, Ioannidis JP. 2002.Role of the Fcg receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: A meta-analysis. Arthritis Rheum 46: 1563-1571.
77. Karnell FG, Brezski RJ, King LB, Silerman MA, Monroe JG. 2005. Membrane cholesterol content accounts for developmental differences in surface B cell receptor compartmentalization and signaling. J Biol Chem 280: 25621-25628.
78. + T regulatory cells. Nat Immunol 4: 337-342.
79. + regulatory T cells is essential for self tolerance. Nature 16: 328-332.
80. Kishimoto H, Sprent J. 2001. A defect in central tolerance in NOD mice. Nat Immunol 2: 1025-1031.
81. + thymocytes. Nature 333: 742-746.
82. + T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 196: 505-515.
83. Kyewski B, Klein L. 2006. A central role for central tolerance. Annu Rev Immunol 24: 571-606.
84. Lafferty KJ, Woolnough J. 1977. The origin and mechanism of the allograft reaction. Immunol Rev 35: 231-262.
85. Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, Meller S, Chamilos G, Sebasigari R, Riccieri V, et al. 2011. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 3: 73ra19.
86. Leadbetter EA, Rifkin IR, Marshak-Rothstein A. 2003. Tolllike receptors and activation of autoreactive B cells. Curr Dir Autoimmun 6: 105-122.
87. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358: 155-157.
88. Lehuen A, Diana J, Zaccone P, Cooke A. 2010. Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 10: 501-513.
89. Lenardo MJ. 1991. Interleukin-2 programs mouse ab T lymphocytes for apoptosis. Nature 353: 858-861.
90. Li H, Jiang Y, Prak EL, Radic M, Weigert M. 2001. Editors and editing of anti-DNA receptors. Immunity 15: 947-957.
91. Li QJ, Chau J, Ebert PJ, Sylvestor G, Min H, Braich R, Manoharan M, Soutschek J, Skare P, Klein LO, et al. 2007. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161.
92. Linsley PS, Clark EA, Ledbetter JA. 1990. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci 87: 5031-5035.
93. Liston A, Lesage S, Gray DH, O'Reilly LA, Strasser A, Fahrer AM, Boyd RL, Wilson J, Baxter AG, Gallo EM, et al. 2004. Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim. Immunity 21: 817-830.
94. Liu S, Velez MG, Humann J, Roland S, Conrad FJ, Halverson R, Torres RM, Palenda R. 2005. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens. J Immunol 175: 5067-5076.
95. + regulatory T cells. Nat Immunol 9: 632-640.
96. Lucas B, Stefanova I, Yasutomo K, Dautigny N, Germain RN. 1999. Divergent changes in the sensitivity of maturing T cells to structurally related ligands underlies formation of a useful T cell repertoire. Immunity 10: 367-376.
97. Macian F, Garcia-Cozar F, Im SH, Horton HF, Byrne MC, Rao A. 2002. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109: 719-731.
98. Martinon F, Tschopp J. 2005. NLRs join TLRs as innate sensors of pathogens. Trends Immunol 26: 447-454.
99. Matzinger P. 1994. Tolerance, danger, and the extended family. Annu Rev Immunol 12: 991-1045.
100. McCormack JE, Callahan JE, Kappler J, Marrack PC. 1993. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol 150: 3785-3792.
101. Means TK, Latz E, Hayashi F, Murali MR, Golenbock DT, Luster AD. 2005. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 115: 407-417.
102. Modigliani Y, Thomas-Vaslin V, Bandeira A, Coltey M, Le Douarin NM, Coutinho A, Salaün J. 1995. Lymphocytes selected in allogeneic thymic epithelium mediate dominant tolerance toward tissue grafts of the thymic epithelium haplotype. Proc Natl Acad Sci 92: 7555-7559.
103. Mohan C, Adams S, Stanik V, Datta SK. 1993.Nucleosomes: A major immunogen for pathogenic autoantibody-inducing T cells in lupus. J Exp Med 177: 1367-1381.
104. Mohan JF, Levisetti MG, Calderon B, Herzog JW, Petzold SJ, Unanue ER. 2010. Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat Immunol 11: 350-354.
105. Mosmann TR, Coffman RL. 1989. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173.
106. Moudgil KD, Sercarz EE. 2005. Understanding cryoticity is the key to revealing the pathogenesis of autoimmunity. Trends Immunol 26: 355-359.
107. Mountz JD, Zhou T, Su X, Cheng J, Pierson M, Bluethmann H, Edwards CK III. 1996. Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways. Behring Inst Mitt 97: 200-219.
108. + regulatory T cells is mediated by cell surface-bound transforming growth factor b. J Exp Med 194: 629-644.
109. Nath SK, Harley JB, Lee YH. 2005. Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: A meta-analysis. Hum Genet 118: 225-234.
110. Nedjic J, Aichinger M, Emmerich J, Mizushima N, Klein L. 2008. Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature 455: 396-400.
111. Nemazee DA, Burki K. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337: 562-566.
112. Nishizuka Y, Sakakura T. 1969. Thymus and reproduction: Sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166: 753-755.
113. Notkins AL. 1977. Virus-induced diabetes mellitus. Arch Virol 54: 1-17.
114. Owen RD. 1945. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 103: 400-401.
115. + T cells. Nat Immunol 8: 1353-1362.
116. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ. 2000. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76: 227-324.
117. Poeck H, Wagner M, Battiany J, Rothenfusser S, Wellisch D, Hornung V, Jahrsdorfer B, Giese T, Endres S, Hartmann G. 2004. Plasmacytoid dendritic cells, antigen, and CpGC license human B cells for plasma cell differentiation and immunoglobulin production in the absence of Tcell help. Blood 103: 3058-3064.
118. Powell JD, Delgoffe GM. 2010. The mammalian target of rapamycin: Linking T cell differentiation, function, and metabolism. Immunity 33: 301-311.
119. + T cells induce wasting disease with multiple organ pathology: Prevention by the Ox-22low subset. J Exp Med 172: 1701-1708.
120. Pugliese A, Zeller M, Fernandez A Jr, Zalcberg LJ, Barlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennett ST, Patel DD. 1997. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15: 293-297.
121. Quezada SA, Jarvinen LZ, Lind EF, Noelle RJ. 2004. CD40/ CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 22: 307-328.
122. + T cells. Proc Natl Acad Sci 98: 241-246.
123. Ramsdell F. 2003. Foxp3 and natural regulatory T cells: Key to a cell lineage? Immunity 19: 165-168.
124. Richez C, Yasuda K, Bonegio RG, Watkins AA, Aprahamian T, Busto P, Richards RJ, Liu CL, Cheung R, Utz PJ, et al. 2010. IFN regulatory factor 5 is required for disease development in the FcgRIIB2/2Yaa and FcgRIIB2/2 mouse models of systemic lupus erythematosus. J Immunol 184: 796-806.
125. Robertson K, Simon K, Schneider S, Timms E, Mitchison A. 1992. Tolerance of self induced in thymus organ culture. Eur J Immunol 22: 207-211.
126. Rocha B, von Boehmer H. 1991. Peripheral selection of the T cell repertoire. Science 251: 1225-1228.
127. Roncarolo MG, Battaglia M. 2007. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 7: 585-598.
128. Sakaguchi S, Sakaguchi N, Asano M, Ito M, Toda M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164.
129. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787.
130. Santiago-Raber ML, Dunand-Sauthier I, Wu T, Li QZ, Uematsu S, Akira S, Reith W, Mohan C, Kotzin BL, Izui S. 2010. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J Autoimmun 34: 339-348.
131. Santori FR, Arsov I, Lilić M, Vukmanović S. 2002. Editing autoreactive TCR enables efficient positive selection. J Immunol 169: 1729-1734.
132. Satoguina J, Mempel M, Larbi J, Badusche M, Loliger C, Adjei O, Gachelin G, Fleischer B, Hoerauf A. 2002. Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). Microbes Infect 4: 1291-1300.
133. Scaffidi P, Misteli T, Bianchi ME. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195.
134. Schwartz RH. 2003. T cell anergy. Annu Rev Immunol 21: 305-334.
135. Schwartz RH. 2008. Immunologic tolerance. In Fundamental immunology, 6th ed. (ed. Paul WE), pp. 898-942. Lippincott Williams & Wilkins, Philadelphia.
136. Seddon B, Mason D. 1999. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med 189: 877-882.
137. Seong SY, Matzinger P. 2004. Hydrophobicity: An ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 4: 469-478.
138. Seroogy CM, Soares L, Ranheim EA, Su L, Holness C, Bloom D, Fathman CG. 2004. The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells. J Immunol 173: 79-85.
139. Sha WC, Nelson CA, Newberry RD, Kranz DM, Russell JH, Loh DY. 1988. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 336: 73-76.
140. + regulatory T cells. Immunol Rev 212: 60-73.
141. Shi Y, Kaliyaperumal A, Lu L, Southwood S, Sette A, Michaels MA, Datta SK. 1998. Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: Role of autoimmune T cell receptor a chain. J Exp Med 187: 367-378.
142. Shi Y, Evans JE, Rock KL. 2003.Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521.
143. Shokat KM, Goodnow CC. 1995. Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature 375: 334-338.
144. Skokos D, Shakhar G, Varma R, Waite JC, Cameron TO, Lindquist RL, Schwickert T, Nussenzweig MC, Dustin ML. 2007. Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes. Nat Immunol 8: 835-844.
145. Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, Vella A, Nutland S, Rance HE, Maier L, et al. 2004. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53: 3020-3023.
146. Sontheimer RD, Racila E, Racila DM. 2005. C1q: Its functions within the innate and adaptive immune responses and its role in lupus autoimmunity. J Invest Dermatol 125: 14-23.
147. Steinman RM, Hawiger D, Nussenzweig MC. 2003. Tolerogenic dendritic cells. Annu Rev Immunol 21: 685-711.
148. Strachan DP. 1989. Hay fever, hygiene, and household size. Br Med J 299: 1259-1260.
149. Surh CD, Sprent J. 1994. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372: 100-103.
150. Suri A, Levisetti MG, Unanue ER. 2008. Do the peptidebinding properties of diabetogenic class II molecules explain autoreactivity? Curr Opin Immunol 20: 105-110.
151. Takeda K, Kaisho T, Akira S. 2003. Toll-like receptors. Annu Rev Immunol 21: 335-376.
152. + T cells in vivo: Multiple thresholds in response to a constant level of antigen presentation. J Immunol 167: 2030-2039.
153. Tang Q, Adams JY, Penaranda C, Melli K, Piaggio E, Sgouroudis E, Piccirillo CA, Salomon BL, Bluestone JA. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
154. Tarasenko T, Dean JA, Bolland S. 2007. FcgRIIB as a modulator of autoimmune disease susceptibility. Autoimmunity 40: 409-417.
155. Tiegs SL, Russell DM, Nemazee D. 1993. Receptor editing in self-reactive bone marrow B cells. J Exp Med 177: 1009-1020.
156. Todd JA. 2010. Etiology of type 1 diabetes. Immunity 32: 457-467.
157. Tze LE, Hippen KL, Behrens TW. 2003. Late immature B cells (IgMhigh IgDneg) undergo a light chain receptor editing response to soluble self-antigen. J Immunol 171: 678-682.
158. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511.
159. Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD, Wagner H. 2002a. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem 277: 15107-15112.
160. Vabulas RM, Braedel S, Hilf N, Singh-Jasuja H, Herter S, Ahmad-Nejad P, Kirschning CJ, Da Costa C, Rammensee HG, Wagner H, et al. 2002b. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J Biol Chem 277: 20847-20853.
161. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG,Wickramasinghe S, Colle E, Polychronakos C. 1997. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 15: 289-292.
162. Vang T, Miletic AV, Arimura Y, Tautz L, Rickert RC,Mustelin T. 2008. Protein tyrosine phosphatases in autoimmunity. Annu Rev Immunol 26: 29-55.
163. Vinuesa CG, Cook MC, Angelucci C, Athanasopoulos V, Rui L, Hill KM, Yu D, Domaschenz H, Whittle B, Lambe T, et al. 2005. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435: 452-458.
164. Von Herrath M, Homann D. 2008. Organ-specific autoimmunity. In Fundamental immunology, 6th ed. (ed. Paul WE), pp. 1331-1374. Lippincott Williams & Wilkins, Philadelphia.
165. Wang A, Batteux F, Wakeland EK. 2010. The role of SLAM/ CD2 polymorphisms in systemic autoimmunity. Curr Opin Immunol 22: 706-714.
166. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317.
167. Watts TH. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23: 23-68.
168. Webb S, Morris C, Sprent J. 1990. Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity. Cell 63: 249-1256.
169. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, et al. 2008. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455: 1109-1113.
170. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 77: 4911-4927.
171. Willis-Karp M, Santeliz J, Karp CL. 2001. The germless theory of allergic disease: Revisiting the hygiene hypothesis. Nat Rev Immunol 1: 69-75.
172. + regulatory T cell function. Science 322: 271-275.
173. Workman CJ, Szymczak-Workman AL, Collison LW, Pillai MR, Vignali DA. 2009. The development and function of regulatory T cells. Cell Mol Life Sci 66: 2603-2622.
174. Yarkoni Y, Getahun A, Cambier JC. 2010.Molecular underpinning of B-cell anergy. Immunol Rev 237: 249-263.
175. Yurasov S, Wardemann H, Hammerson J, Tsuiji M, Meffre E, Pascual V, Nussenzweig MC. 2005. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 201: 703-711.
176. Zha Y, Marks R, Ho AW, Peterson AC, Janardhan S, Brown I, Praveen K, Stang S, Stone JC, Gadjewski TF. 2006. T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-a. Nat Immunol 7: 1166-1173.
177. Zhao ZS, Granucci F, Yeh L, Schaffer PA, Cantor H. 1998. Molecular mimicry by herpes simplex virus-type 1: Autoimmune disease after viral infection. Science 279: 1344-1347.
178. Zhu J, Yamane H, Paul WE. 2010. Differentiation of effector CD4 T cell populations. Annu Rev Immunol 28: 445-489.